November 25, 2012

Toronto, Canada.  (November 25, 2012) Benetech Inc. is a software development company that creates and markets tools for use in prenatal screening.  Its flagship product, Benetech PRA is used daily by hundreds of leading hospitals and labs around the world to screen millions of pregnancies each year for chromosomal anomalies.

Benetech announces today the release of the latest version of its Benetech PRA product, version 2.4.1.1.  Benetech PRA 2.4.1.1 contains several product enhancements and is the first version of PRA to carry the CE Mark in accordance with the requirements of the Council 98/79/EC for in vitro diagnostic medical

August 22, 2012

Toronto, Canada.  (August 22, 2012) Benetech Inc. is a software development company that creates and markets tools for use in prenatal screening. Its flagship product, Benetech PRA is used daily by hundreds of leading hospitals and labs around the world to screen millions of pregnancies each year for chromosomal anomalies.

Benetech announced today that it has received CE Mark approval for its Benetech PRA software product for prenatal screening.  Full information on the certificate is as follows:

EC Certificate – Full Quality Assurance System Approval Certificate
Annex IV, section 3 of Council Directive 98/79/EC on In Vitro Diagnostic Medical Devices

Scope

August 2, 2012

Toronto, Canada.  (August 2, 2012) Benetech Inc. is a software development company that creates and markets tools for use in prenatal screening.  Its flagship product, Benetech PRA is used daily by hundreds of leading hospitals and labs around the world to screen millions of pregnancies each year for chromosomal anomalies.

Benetech announced today that it has received notice from UL LLC® that it has completed its assessment of Benetech’s quality systems and found it in compliance with the guidelines for ISO 13485:2003.

“This marks an important day for our company”, said company founder Ken McEvoy, “ISO standards are the highest